Eli Lilly and Co
XMUN:LLY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
Eli Lilly and Co
XMUN:LLY
|
US |
|
A
|
American International Group Inc
DUS:AINN
|
US |
|
Intesa Sanpaolo SpA
F:IESJ
|
IT |
|
S
|
Schneider Electric SE
XMUN:SND
|
FR |
|
S
|
Saipem SpA
F:SPEA
|
IT |
Wall St Price Targets
LLY Price Targets Summary
Eli Lilly and Co
According to Wall Street analysts, the average 1-year price target for LLY is 1 058.18 EUR with a low forecast of 737.54 EUR and a high forecast of 1 353.08 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is LLY's stock price target?
Price Target
1 058.18
EUR
According to Wall Street analysts, the average 1-year price target for LLY is 1 058.18 EUR with a low forecast of 737.54 EUR and a high forecast of 1 353.08 EUR.
What is the Revenue forecast for Eli Lilly and Co?
Projected CAGR
20%
Over the last 13 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 3 years is 20%.
What is the Gross Profit forecast for Eli Lilly and Co?
Projected CAGR
19%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 9%. The projected CAGR for the next 3 years is 19%.
What is the Operating Income forecast for Eli Lilly and Co?
Projected CAGR
24%
Over the last 13 years, the compound annual growth rate for Operating Income has been 15%. The projected CAGR for the next 3 years is 24%.
What is the Pre-Tax Income forecast for Eli Lilly and Co?
Projected CAGR
31%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 13%. The projected CAGR for the next 3 years is 31%.
What is the Net Income forecast for Eli Lilly and Co?
Projected CAGR
31%
Over the last 13 years, the compound annual growth rate for Net Income has been 13%. The projected CAGR for the next 3 years is 31%.
